HLM/OSBP2 is expressed in chronic myeloid leukemia.

International journal of molecular medicine

Volumn 12, Issue 4, 2003, Pages 663-666

  Henriques Silva, Nathalie ^a   Vasconcellos Fournier, Marcia ^a   Pimenta, Glicinia ^a   Pulcheri, Wolmar Alcantara ^a   Spector, Nelson ^a   da Costa Carvalho, Maria da Gloria ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; OSBP2 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; IMMUNOBLOTTING; LEUKOCYTE; MALE; METABOLISM; MORTALITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOBLOTTING; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES; MALE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 2642537570     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.12.4.663     Document Type: Article

References (0)